Ensysce Biosciences Financial Overview
Ensysce Biosciences's market cap is currently $4.29M. The company's EPS TTM is $-1.29; its P/E ratio is -0.19; Ensysce Biosciences is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.
